SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001544227-20-000035
Filing Date
2020-06-23
Accepted
2020-06-23 07:07:51
Documents
1
Period of Report
2020-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159291045464779.html 4  
1 FORM 4 wf-form4_159291045464779.xml 4 4033
  Complete submission text file 0001544227-20-000035.txt   5506
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVEXIS, INC., 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address
Nuechterlein Carole (Reporting) CIK: 0001665133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 20980273